- VYNE Therapeutics ( NASDAQ: VYNE ) has announced that its Board of Directors has approved a reverse stock split of the Co.’s common stock at a ratio of 1-for-18 .
- The reverse stock split was previously approved by stockholders at the Special Meeting of Stockholders on January 12, 2023.
- The reverse stock split will become effective after market close on Friday, Feb. 10, 2023 and shares will begin trading on a split-adjusted basis when the market opens on Monday, Feb. 13, 2023.
- VYNE -5.96% premarket to $0.2351.
For further details see:
VYNE Therapeutics announces 1-for-18 reverse stock split